In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

As The Lantern at Morning Pointe Alzheimer’s Center of Excellence, East Hamilton gets closer to opening, three central ...

(HealthDay News) — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer’s Association and the Society for Nuclear Medicine ...

In addition to neuropsychology Dr. Gaines also provides therapy for a variety of psychological ... evaluations including forensic, dementia, brain-injury, combat-related PTSD, developmental ...

Fraser is said to have been instrumental in safeguarding the charity’s future, from stepping in to prevent the imminent ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study led by Western researchers suggests that frequent treatment with intranasal o ...

A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...